Drug recall · March 23, 2022
Alprazolam Tablets recall
Why: CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Alprazolam Tablets, USP 1mg, 180-count bottles, Rx only, Manufactured by ULTRAlab Laboratories, Inc., NY; Packaged by GSMS, Inc., CA NDC 60429-504-18.
- Lots / codes
Lot #: GS027852, Expiry: 06/2022.
- Quantity
- 401 bottles
- Company
- Golden State Medical Supply Inc., Camarillo, CA
- Distribution
- Distributed to 1 wholesaler/distributor
- Initiated
- March 2, 2022 · Voluntary: Firm initiated
- Classified
- March 15, 2022
- Reported
- March 23, 2022
- Ended
- September 13, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alprazolam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.